In addition, the elevated circulating asprosin level is closely associated with clinical relevant parameters of metabolic disorders such as type 2 diabetes, obesity, MASLD.[13, 14] However, the precise role of asprosin in the progression of MASLD is still not well understood. This evidence concerns the gene FBN1 and obesity disorder.